Bionik Laboratories Corp. (OTCMKTS:BNKL) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Item 5.02 Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers.

As of July 21, 2017, Hermano Igo Krebs, a director of Bionik Laboratories Corp. (the “Company”), resigned from the Board of Directors of the Company (the “Board”). Mr. Krebs expressed to the Board that he is not in agreement with the strategy and execution by the Company.

Bionik Laboratories Corp. Exhibit
EX-99.1 2 v471251_ex99-1.htm EXHIBIT 99.1   Exhibit 99.1   Dear Board Member,…
To view the full exhibit click here

About Bionik Laboratories Corp. (OTCMKTS:BNKL)

Bionik Laboratories Corp. (Bionik), formerly Drywave Technologies, Inc., is a medical device and robotics company. The Company is focused on providing rehabilitation solutions and developing transformational technologies and solutions to individuals with neurological disorders, specializing in the designing, developing and commercializing of physical rehabilitation technologies, prosthetics and assisted robotic products. It has over three products on the market and approximately three products in various stages of development. The InMotion Systems include the InMotion ARM, InMotion HAND, InMotion Wrist and InMotion ANKLE are designed to provide patent-adaptive therapy in a manner that has been clinically verified to manage neuro-recovery. The Company is also engaged in developing a lower-body exoskeleton, ARKE, which designs to allow paraplegics, as well as other wheelchair users the ability to rehabilitate through walking.